Covidien divests its specialty chemicals unit for $280mm
Covidien Ltd. has divested its specialty chemicals business to an affiliate of private equity firm New Mountain Capital for $280mm in cash.
- Research, Analytical Equipment & Supplies
- Payment Includes Cash for Equity
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.